Mastering Vaccine Guidelines, Timing, and Administration in the IBD Patient
PROGRAM DESCRIPTION Patients with inflammatory bowel disease (IBD) are at an increased risk for infections, however, some of these infections are preventable by vaccination. While immunocompetent IBD patients can generally ...
Patients with inflammatory bowel disease (IBD) are at an increased risk for infections, however, some of these infections are preventable by vaccination. While immunocompetent IBD patients can generally be vaccinated using standard immunization recommendations, there are special considerations for IBD patients receiving immunosuppressive therapy; this is especially important when treatment includes biological therapies. The use of immunosuppressive therapy will influence vaccine recommendations and preventive care counseling by gastroenterologists and the primary care team.Using interactive case scenarios, Gary R. Lichtenstein, MD, and Michael Cirigliano, MD, will explore vaccine-related issues that are relevant to patients with IBD being treated with immunosuppressive biological therapies.
After completing this activity, the participant will be better able to:Assess vaccination status and routine preventive care needs in patients with IBD in accordance with recommended schedulesIndividualize vaccination recommendations in alignment with current guidelines to help mitigate the risk of vaccine-preventable infection in patients with IBDImplement strategies that increase the frequency of guideline-compliant vaccination schedule completion for each IBD patient prior to initiating therapyCoordinate responsibilities for vaccination recommendations, monitoring, and administration among clinicians that care for patients with IBD
I'm interested in this
Share with others
Write the first review
Share with others